Factors in xenograft rejection

Annals of the New York Academy of Sciences

Volumn 875, Issue , 1999, Pages 261-276

  Robson, Simon C ^a,b   Schulte Am Esch II, Jan ^a   Bach, Fritz H ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTICOAGULANT AGENT; ANTIGEN; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10A; CD39 ANTIGEN; COMPLEMENT; GLYCOPROTEIN IB; PROTEIN C; PROTHROMBIN; THROMBIN; THROMBOMODULIN; TISSUE FACTOR PATHWAY INHIBITOR; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

BLOOD CLOTTING; BLOOD VESSEL INJURY; CELL ACTIVATION; COMPLEMENT ACTIVATION; CONFERENCE PAPER; ENDOTHELIUM CELL; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PRIMATE; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SPECIES DIFFERENCE; THROMBOCYTE ACTIVATION; THROMBOSIS; VASCULARIZATION; XENOGRAFT;

PRIMATES; SUIDAE; SUS SCROFA;

EID: 0032767675     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb08509.x     Document Type: Conference Paper

References (131)

1. 1. TANIGUCHI, S. & D. COOPER. 1997. Clinical xenotransplantation - past, present and future [Review]. Ann. Royal Coll. Surg. 79: 13-19.
2. 2. PLATT, J.L. & F.H. BACH. 1991. Discordant xenografting: challenges and controversies. [Review]. Clin. Opin. Immunol. 3: 735-739.
3. 3. PLATT, J. L. 1996. Xenotransplantation - recent progress and current perspectives [Review]. Clin. Opin. Immunol. 8: 721-728.
4. 4. PARKER, W., S. SAADI, S.S. LIN, Z.E. HOLZKNECHT, M. BUSTOS & J.L. PLATT. 1996. Transplantation of discordant xenografts - a challenge revisited [Review]. Immunol. Today 17: 373-378.
5. 5. DORLING, A. & R.I. LECHLER. 1994. Prospects for xenografting [Review]. Clin. Opin. Immunol. 6: 765-769.
6. 6. AUCHINCLOSS, H. & D.H. SACHS. 1998. Xenogeneic Transplantation [Review]. Ann. Rev. Immunol. 16: 433-470.
7. 7. AKIYOSHI, D.E., M. DENARO, H.H. ZHU, J. L. GREENSTEIN, P. BANERJEE & J.A. FISHMAN. 1998. Identification of a full-length cDNA for an endogenous retrovirus of miniature swine. J. Virol. 72: 4503-4507.
8. 8. PATIENCE, C., Y. TAKEUCHI & R.A. WEISS. 1997. Infection of human cells by an endogenous retrovirus of pigs. Nature Med. 3: 282-286.
9. 9. BACH, F.H., J.A. FISHMAN, N. DANIELS, J. PROIMOS, B. ANDERSON, C. B. CARPENTER, L. FORROW, S.C. ROBSON & H.V. FINEBERG. 1998. Uncertainty in xenotransplantation: individual benefit versus collective risk. Nature Med. 4: 141-144.
10. 10. SACHS, D.H., R.B. COLVIN, A.B. COSIMI, P.S. RUSSELL, M. SYKES, C.G.A. MCGREGOR & J.L. PLATT. 1998. Xenotransplantation - caution, but no moratorium. Nature Med. 4: 372.
11. 11. GALILI, U. 1993. Interaction of the natural anti-gal antibody with alpha-galactosyl epitopes - A major obstacle for Xenotransplantation in humans. Immunol. Today 14: 480-482.
12. 12. DALMASSO, A.P., G.M. VERCELLOTTI, R.J. FISCHEL, R.M. BOLMAN, F.H. BACH & J.L. PLATT. 1992. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am. J. Pathol. 140: 1157-1166.
13. 13. COOPER, D., Y. YE, M. NIEKRASZ., et al. 1993. Specific intravenous carbohydrate therapy - a new concept in inhibiting antibody-mediated rejection experience with abo-incompatible cardiac allografting in the baboon. Transplantation 56: 769-777.
14. 14. COOPER, D.K.C., E. KOREN & R. ORIOL. 1994. Alpha-galactosyl oligosaccharides and discordant xenografting. Xenotransplantation 2: 13-18.
15. 15. PLATT, J.L., G.M. VERCELLOTTI, A.P. DALMASSO, A.J. MATAS, R.M. BOLMAN, J.S. NAJARIAN & F.H. BACH. 1990. Transplantation of discordant xenografts: a review of progress [Review]. Immunol. Today. 11: 450-456.
16. 16. MCCURRY, K.R., L.E. DIAMOND, D.L. KOOYMAN, G.W. BYRNE, M.J. MARTIN, J.S. LOGAN & J.L. PLATT. 1996. Human complement regulatory proteins expressed in transgenic swine protect swine xenografts from humoral injury. Transplant. Proc. 28: 2.
17. 17. WHITE, D.J.G. 1996. hDAF transgenic pig organs: are they concordant for human transplantation. Xenotransplantation 4: 50-54.
18. 18. DAVIS, E.A., S.K. PRUITT, P.S. GREENE, S. IBRAHIM, T.T. LAM, J.L. LEVIN, W.M. BALDWIN & F. SANFILIPO. 1996. Inhibition of complement, evoked antibody, and cellular response prevents rejection of pig-to-primate cardiac xenografts. Transplantation 62: 1018-1023.
19. 19. PRUITT, S.K., R.R. BOLLINGER, B.H. COLLINS, H.C. MARSH, J.L. LEVIN, A.R. RUDOLPH, W.M. BALDWIN & F. SANFILIPPO. 1996. Continuous complement (C) inhibition using soluble C receptor type I (SCRI) - effect on hyperacute rejection (HAR) of pig-to-primate cardiac xenografts. Transplant. Proc. 28: 321.
20. 20. BACH, F.H., H. WINKLER, C. FERRAN, W.W. HANCOCK & S.C. ROBSON. 1996. Delayed Xenograft Rejection [Review]. Immunol. Today 17: 379-384.
21. 21. ROSENGARD, A.M., N.R. CARY, G.A. LANGFORD, A.W. TUCKER, J. WALLWORK & D.J. WHITE. 1995. Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs. A potential approach for preventing xenograft rejection. Transplantation 59: 1325-1333.
22. 22. SANDRIN, M.S., W.L. FODOR & E. MOUHTOURIS, et at. 1995. Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nature Med. 1: 1261-1267.
23. 23. SANDRIN, M.S., W.L. FODOR, S. COHNEY, E. MOUHTOURIS, N. OSMAN, S.A. ROLLINS, S. P. SQUINTO & I. MCKENZIE. 1996. Reduction of the major porcine xenoantigen gal-alpha(1,3)gal by expression of alpha(1,2)fucosyltransferase. Xenotransplantation 3: 134-140.
24. 24. BACH, F.H., S.C. ROBSON, C. FERRAN, et al. 1994. Endothelial cell activation and thromboregulation during xenograft rejection [Review]. Immunol. Rev. 141: 5-30.
25. 25. PLATT, J.L. 1998. New directions for organ transplantation [Review]. Nature 392: 11-17.
26. 26. LIN, S.S., B.C. WEIDNER, G.W. BYRNE, et al. 1998. The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J. Clin. Invest. 101: 1745-1756.
27. 27. SCHMOECKEL, M., G. NOLLERT, M. SHAHMOHAMMADl, J. MULLERHOCKER, V.K. YOUNG, W. KASPERKONIG, D.J.G. WHITE, C. HAMMER & B. REICHART. 1997. Transgenic human decay accelerating factor makes normal pigs function as a concordant species. J. Heart Lung Transplant. 16: 758-764.
28. 28. TUCKER, A.W., C.A. CARRINGTON, A.C. RICHARDS, S.C. ROBSON & D.F.G. WHITE. 1997. Endothelial cells from human decay acceleration factor transgenic pigs are protected against complement mediated tissue factor expression in vitro. Transplant. Proc. 29: 888.
29. 29. WHITE, D.J.G., M. SCHMOECKEL, E. Cozzi, G. CHAVEZ & G. LANGFORD. 1997. Genetic engineering of pigs for xenogeneic heart transplantation [French]. Bio-drugs 8: 33-36.
30. 30. COZZI, E., A.W. TUCKER, G.A. LANGFORD, et al. 1997. Characterization of pigs transgenic for human decay-accelerating factor. Transplantation 64: 1383-1392.
31. 31. BACH, F.H., C. FERRAN, M. SOARES, C.J. WRIGHTON, J. ANRATHER, H. WINKLER, S. C. ROBSON & W.W. HANCOCK. 1997. Modification of vascular responses in Xenotransplantation - inflammation and apoptosis. Nature Med. 3: 944-948.
32. 32. GOODMAN, D.J., M. VON ALBERTINI, A. WILLSON, M.T. MILLAN & F.H. BACH. 1996. Direct activation of porcine endothelial cells by human natural killer cells. Transplantation 61: 763-771.
33. 33. MILLAN, M.T., C. GECZY, K.M. STUHLMEIER, D.J. GOODMAN, C. FERRAN & F.H. BACH. 1997. Human monocytes activate porcine endothelial cells, resulting in increased E-selectin, interleukin-8, monocyte chemotactic protein-1, and plasminogen activator inhibitor-type-1 expression. Transplantation 63: 421-429.
34. 34. YAMADA, K., J.D. SEEBACH, H. DERSIMONIAN & D.H. SACHS. 1996. Human anti-pig t-cell mediated cytotoxicity. Xenotransplantation 3: 179-187.
35. 35. SEEBACH, J.D., K. YAMADA, I.M. MCMORROW, D.H. SACHS & H. DERSIMONIAN. 1996. Xenogeneic human anti-pig cytotoxicity mediated by activated natural killer cells. Xenotransplantation 3: 188-197.
36. 36. CANDINAS, D., N. KOYAMADA, T. MIYATAKE, B.A. LESNIKOSKI, S.T. GREY, S.C. ROBSON, F.H. BACH & W.W. HANCOCK. 1995. Delayed xenograft rejection in complement depleted T cell deficient (nude) rat recipients of guinea pig xenografts. Abstract: Proceedings of 3rd International Xenotransplantation Congress, 1995.
37. 37. AUCHINCLOSS, H. 1990. Xenografting: a review. Transplantation 48: 14-20.
38. 38. BALDWIN, W.M.I., S.K. PRUITT, R.B. BRAUER, M.R. DAHA & F. SANFILIPPO. 1995. Complement in organ transplantation. Transplantation 59: 797-808.
39. 39. HANCOCK, W.W., M.L. BLAKELY, W. VAN DER WERF & F.H. BACH. 1993. Rejection of guinea pig cardiac xenografts post-cobra venom factor therapy is associated with infiltration by mononuclear cells secreting interferon-gamma and diffuse endothelial activation. Transplant. Proc. 25: 2932.
40. 40. BACH, F.H., S.C. ROBSON, H. WINKLER, C. FERRAN, K.M. STUHLMEIER, C.J. WRIGHTON & W.W. HANCOCK. 1995. Barriers to xenotransplantation. Nature Med. 1: 869-873.
41. 41. SAADI, S., R.A. HOLZKNECHT, C.P. PATTE, D.M. STERN & J.L. PLATT. 1995. Complement-mediated regulation of tissue factor activity in endothelium. J. Exp. Med. 182: 1807-1814.
42. 42. SAADI, S. & J.L. PLATT. 1995. Transient perturbation of endothelial integrity induced by natural antibodies and complement. J. Exp. Med. 181: 21-31.
43. 43. ROBSON, S.C., V.K. YOUNG, N.S. COOK, et al. 1996. Thrombin inhibition in an ex vivo model of hyperacute xenograft rejection. Transplantation 61: 862-868.
44. 44. ROBSON, S.C., J.B. SIEGEL., B.A. LESNIKOSKI, C. KOPP, D. CANDINAS, U. RYAN & F.H. BACH. 1996. Aggregation of human platelets induced by porcine endothelial cells is dependent upon both activation of complement and thrombin generation. Xenotransplantation 3: 24-34.
45. 45. NORIN, A.J., R.J. BREWER, N. LAWSON, G.A. GRIJALVA, M. VAYNBLATT, W. BURTON, S.P. SQUINTO, S.L. KAMHOLZ & W.L. FODOR. 1996. Enhanced survival of porcine endothelial cells and lung xenografts expressing human cd59. Transplant. Proc. 28: 797-798.
46. 46. DALMASSO, A.P., G.M. VERCELLOTTI, J.L. PLATT & F.H. BACH. 1991. Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor. Potential tor prevention of xenograft hyperacute rejection. Transplantation 52: 530-533.
47. 47. DALMASSO, A.P., J.L. PLATT & F.H. BACH. 1991. Reaction of complement with endothelial cells in a model of xenotransplantation. Clin. Exp. Immunol. 1: 31-35.
48. 48. WHITE, D. 1992. Transplantation of organs between species. Int. Arch. Allergy Immunol. 98: 1-5.
49. 49. WHITE, D., J. WALLWORK. 1993. Xenografting - probability, possibility, or pipe dream? Lancet 342: 879-880.
50. 50. BALDWIN, W.M., S.K. PRUITT, R.B. BKAUER, M.R. DAHA & F. SANFILIPPO. 1995. Complement in organ transplantation - contributions to inflammation, injury, and rejection [Review]. Transplantation 59: 797-808.
51. 51. PRUITT, S.K., A.D. KIRK, R.R. BOLLINGER, et al. 1994. The effect of soluble complement receptor type I on hyperacute rejection of porcine xenografts. Transplantation 57: 363-370.
52. 52. SANDRIN, M.S., H.A. VAUGHAN, P.L. DABKOWSKI & I. MCKENZIE. 1993. Studies on human naturally occurring antibodies to pig xenografts. Transplant. Proc. 25: 2917-2918.
53. 53. VAUGHAN, H.A., I. MCKENZIE & M.S. SANDRIN. 1995. Biochemical studies of pig xenoantigens detected by naturally occurring human antibodies and the galactose-alpha(1-3)galactose reactive lectin. Transplantation 59: 102-109.
54. 54. WATIER, H., J.M. GUILLAUMIN, F. PILLER, M. LACORD, G. THIBAULT, Y. LEBRANCHU, M. MONSIGNY & P. BARDOS. 1996. Removal of terminal alpha-galactosyl residues from xenogeneic porcine endothelial cells - decrease in complement-mediated cytotoxicity but persistence of igg1-mediated antibody-dependent cell-mediated cytotoxicity. Transplantation 62: 105-113.
55. 55. CONWAY, E.M. & R.D. ROSENBERG. 1988. Tumour necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Molec. Cell. Biol. 8: 5588-5592.
56. 56. ESMON, C.T. 1993. Cell mediated events that control blood coagulation and vascular injury [Review]. Ann. Rev. Cell Biol. 9: 1-26.
57. 57. CONWAY, E.M., R. BACH, R.D. ROSENBERG & W.H, KONIGSBERG. 1989. Tumor necrosis factor enhances expression of tissue factor mRNA in endothelial cells. Thromb. Res. 53: 231-241.
58. 58. KOPP, C.W., J.B. SIEGEL, W.W. HANCOCK, J. ANRATHER, H. WINKLER, C.L. GECZY, E. KACZMAREK, F.H. BACH & S.C. ROBSON. 1997. Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors. Transplantation 63: 749-758.
59. 59. GREY, S., A. TSUCHIDA, C.L. ORTHNER, H.H. SALEM & W.W. HANCOCK. 1994. Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-γ or phorbol ester. J. Immunol. 153: 3664-3672.
60. 60. INVERARDI, L., M. SAMAJA, F. MARELLI, J.R. BENDER & R. PARDI. 1992. Cellular early immune recognition of xenogeneic vascular endothelium. Transplant. Proc. 24: 459-461.
61. 61. INVERARDI, L., M. SAMAJA, R. MOTTERLINI, F. MANGILI, J.R. BENDER & R. PARDI. 1992. Early recognition of a discordant xenogeneic organ by human circulating lymphocytes. J. Immunol. 149: 1416-1423.
62. 62. INVERARDI, L., B. CLISSI, A.L. STOLZER, J.R. BENDER, M.S. SANDRIN & R. PARDI. 1997. Human natural killer lymphocytes directly recognize evolutionarily conserved oligosaccharide ligands expressed by xenogeneic tissues. Transplantation 63: 1318-1330.
63. 63. MALYGUINE, A.M., S. SAADI, J.L. PLATT & J.R. DAWSON. 1996. Human natural killer cells induce morphologic changes in porcine endothelial, cell monolayers. Transplantation 61: 161-164.
64. 64. LIN, Y., M. VANDEPUTTE & M. WAER. 1997. Natural killer cell-and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell responses. J. Immunol. 158: 5658-5667.
65. 65. AUCHINCLOSS, H. 1988. Xenogeneic transplantation [Review]. Transplantation 46: 1-20.
66. 66. MOSES, R.D., H.J. WINN & H.J. AUCHINCLOSS. 1992. Evidence that multiple defects in cell-surface molecule interactions across species differences are responsible for diminished xenogeneic T cell responses. Transplantation 53: 203-209.
67. 67. BREVIG, T. & T. KRISTENSEN. 1997. Direct cytotoxic response of human lymphocytes to porcine PHA-lymphoblasts and lymphocytes. APMIS 105: 290-298.
68. 68. VON ALBERTINI, M.A., D.M. STROKA, C. BROSTJAN, K.M. STUHLMEIER, F.H. BACH & S.C. ROBSON. 1997. Adenosine nucleotides induce E-selectin expression in porcine endothelial cells. Transplant. Proc. 29: 1-2. (BBRC. In press).
69. 69. KACZMAREK, E., K. KOZIAK, J. SEVIGNY, J.B. SIEGEL, J. ANRATHER, A.R. BEAUDOIN, F.H. BACH & S.C. ROBSON. 1996. Identification and characterization of CD39 vascular ATP diphosphohydrolase. J. Biol. Chem. 271: 33116-33122.
70. 70. ROBSON, S.C., E. KACZMAREK, J.B. SIEGEL, D. CANDINAS, K. KOZIAK, M. MILLAN, W.W. HANCOCK & F.H. BACH. 1997. Loss of ATP diphosphohydrolase activity with endothelial cell activation. J. Exp. Med. 185: 153-163.
71. 71. PALMETSHOFER, A., U. GALILI, A.P. DALMASSO, S.C. ROBSON & F.H. BACH. 1998. Alpha-galactosyl epitope-mediated activation of porcine aortic endothelial cells -type II activation. Transplantation 65: 971-978.
72. 72. PALMETSHOFER, A., U. GALILI, A.P. DALMASSO, S.C. ROBSON & F.H. BACH. 1998. Alpha-galactosyl epitopce-mediated activation of porcine aortic endothelial cells -type I activation. Transplantation 65: 844-853.
73. 73. PALMETSHOFER, A., S.C. ROBSON & F.H. BACH. 1998. Tyrosine phosphorylation following lectin mediated endothelial cell stimulation. Xenotransplantation 5: 61-66.
74. 74. ANRATHER, D., M.T. MILLAN, A. PALMETSHOFER, S.C. ROBSON, C. GECZY, A.J. RITCHIE, F.H. BACH & B.M. EWENSTEIN. 1997. Thrombin activates nuclear factor-kappa-b and potentiates endothelial cell activation by TNF. J. Immunol. 159: 5620-5628.
75. 75. STROKA, D.M., J.T. COOPER, C. BROSTJAN, M.T. MILLAN, D.J. GOODMAN, C.J. WRIGHTON, F.H. BACH & C. FERRAN. 1997. Expression of a negative dominant mutant of human p55 tumor necrosis factor-receptor inhibits TNF and monocyte-induced activation in porcine aortic endothelial cells. Transplant. Proc. 29: 12.
76. 76. BAEUERLE, P.A. & D. BALTIMORE. 1988. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappaB transcription factor. Cell 53: 211-217.
77. 77. FERRAN, C., M.T. MILLAN, V. CSIZMADIA, J.T. COOPER, C. BROSTJAN, F.H. BACH & H. WINKLER. 1995. Inhibition of NF-κB by pyrrolidine dithiocarbamate blocks endothelial cell activation. BBRC 214: 212-223.
78. 78. ANRATHER, J., V. CSIZMADIA, C. BROSTJAN, M.P. SOARES, F.H. BACH & H. WINKLER. 1997. Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-kappa-B. J. Clin. Invest. 99: 763-772.
79. 79. KIRK, A.D., J.S. HEINLE, J.R. MAULT & F. SANFILIPPO. 1993. Ex-vivo characterization of human anti-porcine hyperacute cardiac rejection. Transplantation 56: 785-793.
80. 80. ROBSON, S.C., V.K. YOUNG, N.S. COOK, G. KOTTIRSCH, J.B. SIEGEL, B.A. LESNIKOSKI, D. CANDINAS, D. WHITE & F.H. BACH. 1996. Inhibition of platelet GPIIbIIIa in an ex vivo model of hyperacute xenograft rejection does not prolong cardiac survival time. Xenotransplantation 3: 43-52.
81. 81. ALMOHANNA, F., K. COLLISON, R. PARHAR, et al. 1997. Activation of naive xenogeneic but not allogeneic endothelial cells by human naive neutrophils - a potential occult barrier to xenotransplantation. Am. J. Pathol. 151: 111-120.
82. 82. MULLIGAN, M.S., M.J. POLLEY, R.J. BAYER, M.F. NUNN, J.C. PAULSON & P.A. WARD. 1992. Neutrophil-dependent acute lung injury - requirement for P-selectin (GMP-140). J. Clin. Invest. 90: 1600-1607.
83. 83. SUGAMA, Y., C. TIRUPPATHI, K. JANAKIDEVI, T.T. ANDERSEN, J.W. FENTON & A.B. MALIK. 1992. Thrombin-induced expression of endothelial P-selectin and intercellular adhesion molecule-1 - a mechanism for stabilizing neutrophil adhesion. J. Cell. Biol. 119: 935-944.
84. 84. COUGHLAN, A.F., M.C. BERNDT, L.C. DUNLOP & W.W. HANCOCK. 1993. In vivo studies of P-selectin and platelet activating factor during endotoxemia, accelerated allograft rejection, and discordant xenograft rejection. Transplant. Proc. 25: 2930-2931.
85. 85. PATEL, K.D., G.A. ZIMMERMAN, S.M. PRESCOTT, R.P. MCEVER & T.M. MCINTYRE. 1991. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J. Cell. Biol. 112: 749-759.
86. 86. XlNG, Z., M. JORDANA, H. KIRFALANI, K.E. DRISCOLL, T.J. SCHALL & J. GAULDIE. 1994. Human NK cells expressing alpha 4 beta 1/beta 7 adhere to VCAM-1 without preactivation. Scand. J. Immunol. 39: 131-136.
87. 87. SEEBACH, J.D., G.L. WANECK. 1997. Natural killer cells in Xenotransplantation [Review]. Xenotransplantation 4: 201-211.
88. 88. IBRAHIM, S., A.D. KIRK & F. SANFILIPPO. 1996. Phenotype of infiltrating cells in an ex vivo model of human antiporcine hyperacute cardiac xenograft rejection. Transplant. Proc. 28: 2.
89. 89. BACH, F.H., S.C. ROBSON, C. FERRAN, et al. 1995. Xenotransplantation: endothelial cell activation and beyond. [Review]. Transplant. Proc. 27: 77-79.
90. 90. NEMERSON, Y. 1992. The tissue factor pathway of blood coagulation. Semin. Hematol. 29: 170-188.
91. 91. KOPP, C.W., S.C. ROBSON, J.B. SIEGEL, J. ANRATHER, H. WINKLER, S. GREY, E. KACZMAREK, F.H. BACH & C.L. GECZY. 1998. Regulation of monocyte tissue factor activity by allogeneic and xenogeneic endothelial cells. Thromb. Haemost. 79: 529-538.
92. 92. SEEBACH, J.D., C. COMRACK, S. GERMANA, C. LEGUERN, D.H. SACHS & H. DERSIMONIAN. 1997. HLA-Cw3 expression on porcine endothelial cells protects against xenogeneic cytotoxicity mediated by a subset of human NK cells. J. Immunol. 159: 3655-3661.
93. 93. GONIAS, S.L. 1994. Demonstration of direct xenorecognition of porcine cells by human cytotoxic T lymphocytes. Immunology 81: 268-272.
94. 94. SPRINGER, T.A. 1994. Indirect presentation of MHC antigens in transplantation. Immunol. Today 15: 32-38.
95. 95. SULTAN, P., A.G. MURRAY, J.M. MCNIFF, M.I. LORBER, P.W. ASKENASE, A. BOTHWELL & J.S. POBER. 1997. Pig but not human interferon-gamma initiates human cell-mediated rejection of pig tissue in vivo. Proc. Natl. Acad. Sci. USA 94: 8767-8772.
96. 96. ROSENBERG, J.C., R.J. BROERSMA, G. BULLEMER, E.F. MAMMEN, R. LENAGHAN & B.F. ROSENBERG. 1969. Relationship of platelets, blood coagulation, and fibrinolysis to hyperacute rejection of renal xenografts. Transplantation 8: 152-161.
97. 97. BROERSMA, R.J., G.D. BULLEMER, J.C. ROSENBERG, R. LENAGHAN, B.F. ROSENBERG & E.F. MAMMEN. 1969. Coagulation changes in hyperacute rejection of renal xenografts. Thromb. Diath. Haem.-Supplementum 36: 333-340.
98. 98. DAVIS, E.A., F. JAKOBS, S.K. PRUITT, et al. 1997. Overcoming rejection in pig-to-primate cardiac xenotransplantation. Transplant. Proc. 29: 938-939.
99. 99. MCCURRY, K.R., D.L. KOOYMAN, C.G. ALVARADO, A.H. COTTERELL, M.J. MARTIN, J. S. LOGAN & J.L. PLATT. 1995. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Med. 1: 423-427.
100. 100. BYRNE, G., K.R. MCCURRY, M.J. MARTIN, S.M. MCCLELLAN, J.L. PLATT & J.S. LOGAN. 1997. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 63: 149-155.
101. 101. SCHULTE, J., J.B. SIEGEL, F.H. BACH & S.C. ROBSON. 1996. The A1 domain of von Willebrand factor expressed on cell membranes directly activates platelets. Blood 88(Suppl.): 1290.
102. 102. PARETI, F.I., M. MAZZUCATO, E. BOTTINI & P.M. MANNUCCI. 1992. Interaction of porcine von Willebrand factor with the platelet glycoproteins Ib and IIb/IIIa complex. Brit. J. Haematol. 82: 81-86.
103. 103. MAZZUCATO, M., L. DEMARCO, P. PRADELLA, A. MASOTTI & F.I. PARETI. 1996. Porcine von willebrand factor binding to human platelet GPIb induces transmembrane calcium influx. Thromb. Haemost. 75: 655-660.
104. 104. BREIMER, M.E., S. BJORCK, C.T. SVALANDER, A. BENGTSSON, L. RYODBERG, K. LIEKARLSEN, P.O. ATTMAN, M. AURELL & B.E. SAMUELSSON. 1996. Extracorporeal (ex vivo) connection of pig kidneys to humans. I. Clinical data and studies of platelet destruction. Xenotransplantation 3: 328-339.
105. 105. COLLINS, B.H., R.S. CHARI, J.C. MAGEE, R.C. HARLAND, B.J. LINDMAN, J.S. LOGAN, R.R. BOLLINGER, W.C. MEYERS & J.L. PLATT. 1995. Immunopathology of porcine livers perfused with blood of humans with fulminant hepatic failure. Transplant. Proc. 27: 280-281.
106. 106. STARZL, T.E., H.J. BOEHMIG, H. AMEMIYA, C.B. WILSON, F.J. DIXON, G.R. GILES, K.M. SIMPSON & C. G. HALGRIMSON. 1970. Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection. New Engl. J. Med. 283: 383-390.
107. 107. STARZL, T.E., R.A. LERNER, F.J. DIXON, C.G. GROTH, L. BRETTSCHNEIDER & P.I. TERASAKI. 1968. Shwartzman reaction after human renal homotransplantation. New Engl. J. Med. 278: 642-648.
108. 108. ROBSON, S.C., D. CANDINAS, W.W. HANCOCK, C. WRIGHTON, H. WINKLER, F.H. BACH. 1995. Role of endothelial cells in transplantation [Review]. Int. Arch. Allerg. Immunol. 106: 305-322.
109. 109. PLATT, J.L., G.M. VERCELLOTI, B.J. LINDMAN, T.R. OEGEMA, F.H. BACH, A.P. DALMASSO. 1990. Release of heparan sulfate from endothelial cells. J. Exp. Med. 171: 1363-1368.
110. 110. ROBSON, S.C. & C. KOPP. 1996. Disordered thromboregulation in discordant xenograft rejection. Life Sci. 6: 34-38.
111. 111. LAWSON, J.H. & J.L. PLATT. 1996. Molecular barriers to xenotransplantation. Transplantation 62: 303-310.
112. 112. DALMASSO, A.P. 1992. The complement system in xenotransplantation. Immunopharmacology 24: 149-160.
113. 113. GREY, S.T. & W.W. HANCOCK. 1996. A physiologic anti-inflammatory pathway based on thrombomodulin expression and generation of activated protein c by human mononuclear phagocytes. J. Immunol. 156: 2256-2263.
114. 114. SIEGEL, J.B., S.T. GREY, B. A. LESNIKOSKI, C.W. KOPP, M. SOARES, J. ESCH, F.H. BACH & S.C. ROBSON. 1997. Xenogeneic endothelial cells activate human prothrombin. Transplantation. 64: 888-896.
115. 115. LAWSON, J.H., L.J. DANIELS & J.L. PLATT. 1997. The evaluation of thrombomodulin activity in porcine to human xenotransplantation. Transplant. Proc. 29: 884-885.
116. 116. JURD, K.M., R.V. GIBBS & B.J. HUNT. 1996. Activation of human prothrombin by porcine aortic endothelial cells - a potential barrier to pig to human xenotransplantation. Blood Coag. Fibrinol. 7: 336-343.
117. 117. VANTVEER, C., N.J. GOLDEN, M. KALAFATIS & K.G. MANN. 1997. Inhibitory mechanism of the protein C pathway on tissue factor-induced thrombin generation - synergistic effect in combination with tissue factor pathway inhibitor. J. Biol. Chem. 272: 7983-7994.
118. 118. VANTVEER, C. & K.G. MANN. 1997. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, anti-thrombin-iii, and heparin cofactor-ii. J. Biol. Chem. 272: 4367-4377.
119. 119. VAN, T, VEER, C., T.M. HACKENG, C. DELAHAYE, J.J. SIXMA & B.N. BOUMA. 1994. Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor. Blood 84: 1132-1142.
120. 120. LESNIKOSKI, B.A., D. CANDINAS, I. OTSU, R. METTERNICH, F.H. BACH & S.C. ROBSON. 1997. Thrombin inhibition in discordant xenograft rejection. Xenotransplantation 4: 140-146.
121. 121. JAKOBS, F.M., E.A. DAVIS, T. WHITE, F. SANFILIPPO & W.M. BALDWIN. 1998. Prolonged discordant xenograft survival by inhibition of the intrinsic coagulation pathway in complement c6-deficient recipients. J. Heart Lung Transplant. 17: 306-311.
122. 122. CANDINAS, D., N. KOYAMADA, T. MIYATAKE, J. SIEGEL, W.W. HANCOCK, F.H. BACH & S.C. ROBSON. 1996. Loss of rat glomerular ATP diphosphohydrolase activity during reperfusion injury is associated with oxidative stress reactions. Thromb. Haemost. 76: 807-812.
123. 123. ROBSON, S.C. 1994. Platelets in xenograft rejection. Xenotransplantation 2: 38-46.
124. 124. PEERSCHKE, E.I.B., K.B.M. REID & B. GHEBREHIWET. 1993. Platelet activation by C1q results in the induction of αII/βIII integrins and the expression of P-selectin and procoagulant activity. J. Exp. Med. 178: 579-587.
125. 125. AMIRKHOSRAVI, A., M. ALEXANDER, K. MAY, D.A. FRANCIS, G. WARNES, J. BIGERSTAFF & J.L. FRANCIS. 1996. The importance of platelets in the expression of monocyte tissue factor antigen measured by a new whole blood flow cytometric assay. Thromb. Haemost. 75: 87-95.
126. 126. SCHULTE AM ESCH, J., J.B. SIEGEL, M. CRUZ, J. ANRATHER & S.C. ROBSON. 1997. The A1 domain of von Willebrand factor expressed on cell membranes directly activates platelets. Blood 90: 4425-4437.
127. 127. CANDINAS, D., B.A. LESNIKOSKI, W.W, HANCOCK, I. OTSU, N. KOYAMADA, A.P. DALMASSO, S.C. ROBSON & F.H. BACH. 1996. Inhibition of platelet integrinGPIIbI-IIa prolongs survival of discordant cardiac xenografts. Transplantation 62: 1-5.
128. 128. MAKOWKA, L., F.A. CHAPMAN, D.V. CRAMER, S.G. QIAN, H. SUN & T.E. STARZL. 1990. Platelet-activating factor and hyperacute rejection. The effect of a platelet-activating factor antagonist, SRI 63-441, on rejection of xenografts and allografts in sensitized hosts. Transplantation 50: 359-365.
129. 129. OHAIR, D.P., A.M. ROZA, R. KOMOROWSKI, G. MOORE, R.P. MCMANUS, C.P. JOHNSON, M.B. ADAMS & G.M. PIEPER. 1993. Tulopafant, a PAF receptor antagonist, increases capillary patency and prolongs survival in discordant cardiac xenotransplants. J. Lipid Med. 7: 79-84.
130. 130. KOYAMADA, N., T. MIYATAKE, D. CANDINAS, P. HECHENLEITNER, J. SIEGEL, W.W. HANCOCK, F.H. BACH & S.C. ROBSON. 1996. Apyrase administration prolongs discordant xenograft survival. Transplantation 62: 1739-1743.
131. 131. FAY, W.P., J.G. MURPHY & W.G. OWEN. 1996. High concentrations of active plasminogen activator inhibitor-1 in porcine coronary artery thrombi. Arterioscl. Thromb. Vasc. Biol. 16: 1277-1284.